Skip to main content
. 2020 Oct 10;13(10):300. doi: 10.3390/ph13100300

Figure 10.

Figure 10

siRNA transfection efficacy evaluation: (a) reduction of GFP production after treatment of MDA-MB-231 cells with carrier/siRNA complexes. ** p < 0.01 when compared with cells treated by naked anti-GFP siRNA. The data are shown as the mean ± S.E.M. (b) reduction of VEGFA gene expression after treatment of E.A.Hy926 cells with carrier/siRNA complexes. The level of VEGFA gene expression after delivery of mock siRNA was taken as 100%. * p < 0.05, ** p < 0.01 when compared with cells treated by naked mock siRNA. The data are shown as the mean ± S.E.M.